BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Frigati LJ, Kranzer K, Cotton MF, Schaaf HS, Lombard CJ, Zar HJ. The impact of isoniazid preventive therapy and antiretroviral therapy on tuberculosis in children infected with HIV in a high tuberculosis incidence setting. Thorax. 2011;66:496-501. [PMID: 21460373 DOI: 10.1136/thx.2010.156752] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Santos JM, Fachi MM, Beraldi-Magalhães F, Böger B, Junker AM, Domingos EL, Imazu P, Fernandez-Llimos F, Tonin FS, Pontarolo R. Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents. J Infect Chemother 2022:S1341-321X(22)00249-5. [PMID: 36075488 DOI: 10.1016/j.jiac.2022.08.023] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Alebel A, Demant D, Petrucka P, Sibbritt D. Effects of undernutrition on mortality and morbidity among adults living with HIV in sub-Saharan Africa: a systematic review and meta-analysis. BMC Infect Dis 2021;21:1. [PMID: 33390160 DOI: 10.1186/s12879-020-05706-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 69] [Article Influence: 40.0] [Reference Citation Analysis]
3 Hunter OF, Kyesi F, Ahluwalia AK, Daffé ZN, Munseri P, von Reyn CF, Adams LV. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania. BMC Infect Dis 2020;20:738. [PMID: 33028260 DOI: 10.1186/s12879-020-05471-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
4 Boti Sidemo N, Hussen Hebo S. Nutritional Status and Its Effect on Treatment Outcome among HIV-Infected Children Receiving First-Line Antiretroviral Therapy in Arba Minch General Hospital and Arba Minch Health Center, Gamo Zone, Southern Ethiopia: Retrospective Cohort Study. Nutrition and HIV/AIDS - Implication for Treatment, Prevention and Cure 2020. [DOI: 10.5772/intechopen.85851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Ngugi SK, Muiruri P, Odero T, Gachuno O. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study. BMC Infect Dis 2020;20:294. [PMID: 32664847 DOI: 10.1186/s12879-020-05011-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
6 LaCourse SM, Richardson BA, Kinuthia J, Warr AJ, Maleche-Obimbo E, Matemo D, Cranmer LM, Escudero JN, Hawn TR, John-Stewart GC. Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children. BMJ Open 2020;10:e034308. [PMID: 31969368 DOI: 10.1136/bmjopen-2019-034308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Geremew D, Endalamaw A, Negash M, Eshetie S, Tessema B. The protective effect of isoniazid preventive therapy on tuberculosis incidence among HIV positive patients receiving ART in Ethiopian settings: a meta-analysis. BMC Infect Dis 2019;19:405. [PMID: 31077133 DOI: 10.1186/s12879-019-4031-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
8 Zar HJ, Gray D. Respiratory Disorders in Human Immunodeficiency Virus–Infected Children and Adolescents. Kendig's Disorders of the Respiratory Tract in Children 2019. [DOI: 10.1016/b978-0-323-44887-1.00066-3] [Reference Citation Analysis]
9 Rendon A, Goletti D, Matteelli A. Diagnosis and treatment of latent tuberculosis infection. Tuberculosis. [DOI: 10.1183/2312508x.10022617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Endalamaw A, Engeda EH, Tezera N. Incidence of tuberculosis in children on antiretroviral therapy: a retrospective cohort study. BMC Res Notes 2018;11:745. [PMID: 30342550 DOI: 10.1186/s13104-018-3846-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
11 Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis 2019;19:e96-e108. [PMID: 30322790 DOI: 10.1016/S1473-3099(18)30157-9] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 11.8] [Reference Citation Analysis]
12 Sekadde MP, Kay AW. Tuberculosis Prevention: an Under Prioritized yet Critical Intervention to Reduce Child Tuberculosis Morbidity and Mortality. Curr Trop Med Rep 2018;5:51-8. [DOI: 10.1007/s40475-018-0139-5] [Reference Citation Analysis]
13 Zeldow B, Kim S, McSherry G, Cotton MF, Jean-Philippe P, Violari A, Bobat R, Nachman S, Mofenson LM, Madhi SA, Mitchell C. Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041. Int J Tuberc Lung Dis 2017;21:38-45. [PMID: 28157463 DOI: 10.5588/ijtld.16.0149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Carmone A, Rodriguez CA, Frank TD, Kiromat M, Bongi PW, Kuno RG, Palou T, Franke MF. Increasing isoniazid preventive therapy uptake in an HIV program in rural Papua New Guinea. Public Health Action 2017;7:193-8. [PMID: 29201654 DOI: 10.5588/pha.17.0011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Zunza M, Gray DM, Young T, Cotton M, Zar HJ. Isoniazid for preventing tuberculosis in HIV-infected children. Cochrane Database Syst Rev 2017;8:CD006418. [PMID: 28850172 DOI: 10.1002/14651858.CD006418.pub3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
16 Davies MA, Gibb D, Turkova A. Survival of HIV-1 vertically infected children. Curr Opin HIV AIDS 2016;11:455-64. [PMID: 27716730 DOI: 10.1097/COH.0000000000000303] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 6.6] [Reference Citation Analysis]
17 Dodd PJ, Prendergast AJ, Beecroft C, Kampmann B, Seddon JA. The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis. Thorax 2017;72:559-75. [PMID: 28115682 DOI: 10.1136/thoraxjnl-2016-209421] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
18 Rabie H, Marais BJ. Tuberculosis and Other Opportunistic Infections in HIV-Infected Children. Viral Infections in Children, Volume I 2017. [DOI: 10.1007/978-3-319-54033-7_4] [Reference Citation Analysis]
19 Rabie H, Goussard P. Tuberculosis and pneumonia in HIV-infected children: an overview. Pneumonia (Nathan) 2016;8:19. [PMID: 28702298 DOI: 10.1186/s41479-016-0021-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
20 Koné Z, Coulibaly G, Daix AT, Bakayoko AS, Samaké K, Kouassi DP, Domoua KM. [Current situation of primary prophylaxis with isoniazid (INH) in children who are contacts of patients with bacillary pulmonary tuberculosis in Abidjan (Cote d'Ivoire)]. Rev Pneumol Clin 2016;72:340-5. [PMID: 27776945 DOI: 10.1016/j.pneumo.2016.08.003] [Reference Citation Analysis]
21 Costenaro P, Massavon W, Lundin R, Nabachwa SM, Fregonese F, Morelli E, Alowo A, Nannyonga Musoke M, Namisi CP, Kizito S, Bilardi D, Mazza A, Cotton MF, Giaquinto C, Penazzato M. Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience. J Acquir Immune Defic Syndr 2016;71:e1-8. [PMID: 26761275 DOI: 10.1097/QAI.0000000000000806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
22 Davies MA, Pinto J, Bras M. Getting to 90-90-90 in paediatric HIV: What is needed? J Int AIDS Soc 2015;18:20770. [PMID: 28326130 DOI: 10.7448/IAS.18.7.20770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
23 Rabie H, Frigati L, Hesseling AC, Garcia-Prats AJ. Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected children. J Int AIDS Soc 2015;18:20236. [PMID: 26639110 DOI: 10.7448/IAS.18.7.20236] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
24 Ford N, Shubber Z, Meintjes G, Grinsztejn B, Eholie S, Mills EJ, Davies M, Vitoria M, Penazzato M, Nsanzimana S, Frigati L, O'brien D, Ellman T, Ajose O, Calmy A, Doherty M. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. The Lancet HIV 2015;2:e438-44. [DOI: 10.1016/s2352-3018(15)00137-x] [Cited by in Crossref: 161] [Cited by in F6Publishing: 174] [Article Influence: 23.0] [Reference Citation Analysis]
25 Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Evid Based Child Health. 2014;9:169-294. [PMID: 25404581 DOI: 10.1002/ebch.1962] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
26 Pitcher RD, Lombard CJ, Cotton MF, Beningfield SJ, Workman L, Zar HJ. Chest radiographic abnormalities in HIV-infected African children: a longitudinal study. Thorax 2015;70:840-6. [PMID: 26060256 DOI: 10.1136/thoraxjnl-2014-206105] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
27 Akolo C, Bada F, Okpokoro E, Nwanne O, Iziduh S, Usoroh E, Ali T, Ibeziako V, Oladimeji O, Odo M. Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons. World J Virology 2015; 4(2): 105-112 [PMID: 25964875 DOI: 10.5501/wjv.v4.i2.105] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
28 Abuogi LL, Mwachari C, Leslie HH, Shade SB, Otieno J, Yienya N, Sanguli L, Amukoye E, Cohen CR. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya. Int J Tuberc Lung Dis 2013;17:1291-7. [PMID: 24025380 DOI: 10.5588/ijtld.12.0740] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
29 Dangor Z, Izu A, Hillier K, Solomon F, Beylis N, Moore DP, Nunes MC, Madhi SA. Impact of the antiretroviral treatment program on the burden of hospitalization for culture-confirmed tuberculosis in South African children: a time-series analysis. Pediatr Infect Dis J 2013;32:972-7. [PMID: 23503163 DOI: 10.1097/INF.0b013e31828d9aa4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
30 Modi S, Chiu A, Ng'eno B, Kellerman SE, Sugandhi N, Muhe L; Child Survival Working Group of the Interagency Task Team on the Prevention and Treatment of HIV Infection in Pregnant Women, Mothers and Child. Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings. AIDS 2013;27 Suppl 2:S159-67. [PMID: 24361625 DOI: 10.1097/QAD.0000000000000080] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
31 Sharma SK, Sharma A, Kadhiravan T, Tharyan P. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Cochrane Database Syst Rev 2013;:CD007545. [PMID: 23828580 DOI: 10.1002/14651858.CD007545.pub2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
32 Cruz AT, Mandalakas AM. New advances in the diagnosis and treatment of pediatric tuberculosis. Clinical Investigation 2013;3:69-82. [DOI: 10.4155/cli.12.139] [Reference Citation Analysis]
33 Marquez L, Starke JR. Diagnosis and management of TB in children: an update. Expert Rev Anti Infect Ther 2011;9:1157-68. [PMID: 22114966 DOI: 10.1586/eri.11.144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Getahun H, Sculier D, Sismanidis C, Grzemska M, Raviglione M. Prevention, diagnosis, and treatment of tuberculosis in children and mothers: evidence for action for maternal, neonatal, and child health services. J Infect Dis 2012;205 Suppl 2:S216-27. [PMID: 22448018 DOI: 10.1093/infdis/jis009] [Cited by in Crossref: 63] [Cited by in F6Publishing: 75] [Article Influence: 6.3] [Reference Citation Analysis]
35 Kattan M, Zar HJ. Respiratory Disorders in Pediatric HIV Infection. Kendig & Chernick’s Disorders of the Respiratory Tract in Children 2012. [DOI: 10.1016/b978-1-4377-1984-0.00063-2] [Reference Citation Analysis]